Treatment of Pediatric Overweight and Obesity: Assessing the Options

Nahid Ranjbar1, Ashley Kurien1, Cheryl A Hall1

  • 1Department Physical Therapy, New York Institute of Technology, Old Westbury, NY 11568.

Insights

Pediatric obesity management is most effective with a multidisciplinary approach combining physical activity, nutrition, and behavioral strategies. These combined interventions significantly impact body mass index (BMI) and weight changes in children.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Behavioral Science

Background:

  • Childhood obesity is a major health epidemic in the U.S.
  • It affects both adults and children.
  • Numerous healthcare interventions target this issue.

Purpose of the Study:

  • To review and evaluate current practices for managing pediatric overweight and obesity.
  • To assess the effectiveness of various intervention strategies.

Main Methods:

  • Systematic review of 82 sources.
  • Inclusion of 24 studies (RCTs and cohort studies) based on PEDro scale evaluation.
  • Examination of interventions in physical activity, nutrition, behavior, pharmaceuticals, and surgery.

Main Results:

  • Combined interventions focusing on reduced sedentary behavior and nutritional changes showed significant results.
  • These strategies led to notable changes in body mass index (BMI) and weight.
  • Multidisciplinary approaches yielded the most positive outcomes.

Conclusions:

  • A multidisciplinary approach integrating physical activity, nutrition, and behavioral strategies is crucial for successful pediatric obesity management.
  • Behavioral interventions should complement and reinforce nutritional and physical activity modifications.
  • Pharmaceutical and surgical options are reserved for cases where other interventions have failed due to potential health risks.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
781
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
162
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
175
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
649
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
367